Leigh syndrome with cardiomyopathy (Q89274): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Trata-se de distúrbio neurometabólico raro que afeta o sistema nervoso central. Esse diagnóstico ocorre com a deterioração mensurável da função do miocárdio (o músculo cardíaco) por qualquer motivo, geralmente levando à insuficiência cardíaca; os sintomas comuns são dispneia e edema periférico. | |||
| description / en | description / en | ||
This refers to a rare neurometabolic disorder that affects the central nervous system. This diagnosis is with the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnoea (breathlessness) and peripheral oedema (swelling of the legs). | |||
Revision as of 15:53, 15 August 2026
This refers to a rare neurometabolic disorder that affects the central nervous system. This diagnosis is with the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnoea (breathlessness) and peripheral oedema (swelling of the legs).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_583594497 |
||
| English | Leigh syndrome with cardiomyopathy |
This refers to a rare neurometabolic disorder that affects the central nervous system. This diagnosis is with the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnoea (breathlessness) and peripheral oedema (swelling of the legs). |
